المؤلفون: Kollmannsberger, CK, Tandstad, T, Bedard, PL, Jewett, MAS, Cohn-Cedermark, G, Chung, PWM, Daugaard, G, Warde, PR, Moore, MJ, Nichols, CR

المصدر: JOURNAL OF CLINICAL ONCOLOGY. 31(15)

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:128992109

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Parker CC; The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK., Clarke NW; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, University of Manchester, Manchester, UK; Department of Urology, Salford Royal Hospital, Salford, UK., Cook AD; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Kynaston H; Division of Cancer and Genetics, Cardiff University Medical School, Cardiff, UK., Catton CN; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Cross WR; Department of Urology, St James's University Hospital, Leeds, UK., Petersen PM; Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Persad RA; Department of Urology, Bristol Urological Institute, Bristol, UK., Saad F; Department of Urology, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada., Bower LC; The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK; Guy's and St Thomas' NHS Foundation Trust, London, UK., Logue J; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK., Payne H; The Prostate Centre, London, UK., Forcat S; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Goldstein C; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Murphy C; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Anderson J; Department of Clinical Oncology, St James's University Hospital, Leeds, UK., Barkati M; Department of Radiation Oncology, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada., Bottomley DM; Department of Clinical Oncology, St James's University Hospital, Leeds, UK., Branagan J; Northampton General Hospital, Northampton, UK., Choudhury A; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, University of Manchester, Manchester, UK., Chung PWM; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada., Cogley L; Derriford Hospital, Plymouth, UK., Goh CL; Royal Surrey Hospital, Guildford, UK., Hoskin P; Division of Cancer Sciences, University of Manchester, Manchester, UK; Mount Vernon Cancer Centre, Northwood, UK., Khoo V; The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK., Malone SC; The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada., Masters L; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Morris SL; Guy's and St Thomas' NHS Foundation Trust, London, UK., Nabid A; Service de Radio-Oncologie, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada., Ong AD; Max Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada., Raman R; Kent Oncology Centre, Kent and Canterbury Hospital, Canterbury, UK., Tarver KL; Department of Oncology, Queen's Hospital, Romford, UK., Tree AC; The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK., Worlding J; University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK., Wylie JP; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK., Zarkar AM; Department of Oncology, University Hospitals Birmingham, Birmingham, UK., Parulekar WR; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada., Parmar MKB; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Sydes MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. Electronic address: mrcctu.radicals@ucl.ac.uk.

مؤلفون مشاركون: RADICALS investigators

المصدر: Lancet (London, England) [Lancet] 2024 Jun 01; Vol. 403 (10442), pp. 2405-2415. Date of Electronic Publication: 2024 May 16.

نوع المنشور: Journal Article; Randomized Controlled Trial; Multicenter Study; Comparative Study

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Neoplasms*/pathology , Prostatic Neoplasms*/radiotherapy , Prostatic Neoplasms*/therapy , Prostatic Neoplasms*/drug therapy , Androgen Antagonists*/therapeutic use , Androgen Antagonists*/administration & dosage , Prostatectomy* , Tosyl Compounds*/therapeutic use , Tosyl Compounds*/administration & dosage , Anilides*/therapeutic use , Anilides*/administration & dosage , Nitriles*/therapeutic use , Nitriles*/administration & dosage, Humans ; Male ; Aged ; Middle Aged ; Oligopeptides/therapeutic use ; Oligopeptides/administration & dosage ; Gonadotropin-Releasing Hormone/agonists ; Combined Modality Therapy ; Prostate-Specific Antigen/blood

المؤلفون: Parker CC; The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK., Kynaston H; Division of Cancer and Genetics, Cardiff University Medical School, Cardiff, UK., Cook AD; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Clarke NW; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, University of Manchester, Manchester, UK; Department of Urology, Salford Royal Hospital, Salford, UK., Catton CN; Princess Margaret Cancer Centre, Toronto, ON, Canada., Cross WR; Department of Urology, St James's University Hospital, Leeds, UK., Petersen PM; Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Persad RA; Department of Urology, Bristol Urological Institute, Bristol, UK., Pugh CA; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Saad F; Department of Urology, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada., Logue J; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK., Payne H; The Prostate Centre, London, UK., Bower LC; The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK; Guy's and St Thomas' NHS Foundation Trust, London, UK., Brawley C; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Rauchenberger M; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Barkati M; Department of Radiation Oncology, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada., Bottomley DM; Department of Clinical Oncology, St James's University Hospital, Leeds, UK., Brasso K; Department of Urology, Copenhagen Prostate Cancer Center, Rigshospitalet, Copenhagen, Denmark., Chung HT; Department of Radiation Oncology, Sunnybrook Odette Cancer Centre, Toronto, ON, Canada; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada., Chung PWM; Princess Margaret Cancer Centre, Toronto, ON, Canada; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada., Conroy R; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK., Falconer A; Radiotherapy Department, Charing Cross Hospital, London, UK., Ford V; Royal Devon and Exeter University NHS Foundation Trust, Exeter, UK., Goh CL; Royal Surrey County Hospital, Guildford, UK., Heath CM; Department of Clinical Oncology, University Hospital Southampton NHS Foundation Trust, Southampton, UK., James ND; The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK., Kim-Sing C; Department of Radiation Oncology, BC Cancer-Vancouver, Vancouver, BC, Canada., Kodavatiganti R; Glan Clwyd Hospital, Betsi Cadwaladr University Health Board, Bangor, UK., Malone SC; The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada., Morris SL; Guy's and St Thomas' NHS Foundation Trust, London, UK., Nabid A; Service de Radio-Oncologie, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada., Ong AD; Max Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada., Raman R; Kent Oncology Centre, Kent and Canterbury Hospital, Canterbury, UK., Rodda S; Bradford Teaching Hospitals, Bradford, UK., Wells P; Barts Cancer Centre, St Bartholomew's Hospital, London, UK., Worlding J; University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK., Parulekar WR; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada., Parmar MKB; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Sydes MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. Electronic address: mrcctu.radicals@ucl.ac.uk.

مؤلفون مشاركون: RADICALS investigators

المصدر: Lancet (London, England) [Lancet] 2024 Jun 01; Vol. 403 (10442), pp. 2416-2425. Date of Electronic Publication: 2024 May 16.

نوع المنشور: Journal Article; Randomized Controlled Trial; Comparative Study; Multicenter Study

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Neoplasms*/pathology , Prostatic Neoplasms*/radiotherapy , Prostatic Neoplasms*/drug therapy , Prostatic Neoplasms*/therapy , Prostatic Neoplasms*/surgery , Androgen Antagonists*/therapeutic use , Androgen Antagonists*/administration & dosage , Prostatectomy* , Tosyl Compounds*/therapeutic use , Tosyl Compounds*/administration & dosage , Anilides*/therapeutic use , Anilides*/administration & dosage , Nitriles*/therapeutic use , Nitriles*/administration & dosage, Humans ; Male ; Aged ; Middle Aged ; Oligopeptides/administration & dosage ; Oligopeptides/therapeutic use ; Gonadotropin-Releasing Hormone/agonists ; Prostate-Specific Antigen/blood ; Combined Modality Therapy ; Drug Administration Schedule

المؤلفون: Perera JR; Orthopaedic Oncology, Royal National Orthopaedic Hospital, London, United Kingdom. Electronic address: Jonathan.Perera@nhs.net., AlFaraidy M; University Musculoskeletal Oncology Unit, Sinai Health System, Division of Orthopaedic Surgery, Department of Surgery, University of Toronto, Toronto, ON, Canada., Ibe I; Orthopaedic Oncology, University of Mississippi Medical Center, USA., Aoude A; Orthopaedic Oncology, McGill University, Montreal, QC, Canada., Acem I; Surgical Oncology and Gastrointestinal Surgery Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Orthopaedic Oncology Leiden University Medical Centre, Leiden, the Netherlands., van de Sande MAJ; Orthopaedic Oncology Leiden University Medical Centre, Leiden, the Netherlands., Dessureault M; Orthopaedic Oncology, McGill University, Montreal, QC, Canada., Turcotte RE; Orthopaedic Oncology, McGill University, Montreal, QC, Canada., Mottard S; Orthopaedic Oncology Université de Montreal, Montreal, QC, Canada., Basile G; Orthopaedic Oncology Université de Montreal, Montreal, QC, Canada., Isler M; Orthopaedic Oncology Université de Montreal, Montreal, QC, Canada., Saint-Yves H; Orthopaedic Oncology Université de Montreal, Montreal, QC, Canada., Eastley N; Orthopaedic Oncology, Royal Orthopaedic Hospital, Birmingham, United Kingdom., Stevenson J; Orthopaedic Oncology, Royal Orthopaedic Hospital, Birmingham, United Kingdom., Houdek MT; Orthopaedic Oncology, Mayo Clinic, Rochester, MN, USA., Chung PWM; Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada., Griffin AM; University Musculoskeletal Oncology Unit, Sinai Health System, Division of Orthopaedic Surgery, Department of Surgery, University of Toronto, Toronto, ON, Canada., Ferguson P; University Musculoskeletal Oncology Unit, Sinai Health System, Division of Orthopaedic Surgery, Department of Surgery, University of Toronto, Toronto, ON, Canada., Wunder JS; University Musculoskeletal Oncology Unit, Sinai Health System, Division of Orthopaedic Surgery, Department of Surgery, University of Toronto, Toronto, ON, Canada., Tsoi KM; University Musculoskeletal Oncology Unit, Sinai Health System, Division of Orthopaedic Surgery, Department of Surgery, University of Toronto, Toronto, ON, Canada.

المصدر: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2023 Feb; Vol. 49 (2), pp. 362-367. Date of Electronic Publication: 2022 Sep 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 8504356 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2157 (Electronic) Linking ISSN: 07487983 NLM ISO Abbreviation: Eur J Surg Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Liposarcoma, Myxoid*/pathology , Liposarcoma* , Sarcoma*/surgery , Soft Tissue Neoplasms*/surgery, Adult ; Humans ; Neoadjuvant Therapy ; Treatment Outcome ; Extremities/pathology ; Retrospective Studies ; Neoplasm Recurrence, Local/surgery

المؤلفون: Nasser NJ; Department of Radiation Oncology, Elmhurst Hospital Center, NYC Health + Hospitals, Queens, NY, USA., Saibishkumar EP; British Columbia Cancer Agency, Victoria, British Columbia, Canada., Wang Y; Department of Radiation Physics, Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Chung PWM; Department of Radiation Oncology, Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Breen SL; Odette Cancer Centre - Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

المصدر: Journal of contemporary brachytherapy [J Contemp Brachytherapy] 2022 Aug; Vol. 14 (4), pp. 354-363. Date of Electronic Publication: 2022 Aug 31.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Termedia Pub. House Country of Publication: Poland NLM ID: 101506276 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1689-832X (Print) Linking ISSN: 20812841 NLM ISO Abbreviation: J Contemp Brachytherapy Subsets: PubMed not MEDLINE

المؤلفون: Ito E; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, M5G 2M9, Canada., Moraes FY; Department of Oncology, Queen's University, Kingston, Ontario, Canada., Ramotar M; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, M5G 2M9, Canada., Lunsky I; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, M5G 2M9, Canada., Soliman H; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.; Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Catton CN; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, M5G 2M9, Canada.; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada., Kassam Z; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.; Stronach Regional Cancer Centre, Newmarket, Ontario, Canada., Morton G; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.; Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Tosoni S; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, M5G 2M9, Canada., Gospodarowicz M; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, M5G 2M9, Canada.; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada., Wong RKS; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, M5G 2M9, Canada.; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada., Liu FF; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, M5G 2M9, Canada.; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada., Chung PWM; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, M5G 2M9, Canada. Peter.Chung@rmp.uhn.ca.; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada. Peter.Chung@rmp.uhn.ca.

المصدر: Journal of cancer education : the official journal of the American Association for Cancer Education [J Cancer Educ] 2021 Dec; Vol. 36 (6), pp. 1295-1305.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: England NLM ID: 8610343 Publication Model: Print Cited Medium: Internet ISSN: 1543-0154 (Electronic) Linking ISSN: 08858195 NLM ISO Abbreviation: J Cancer Educ Subsets: MEDLINE

مواضيع طبية MeSH: Internship and Residency* , Radiation Oncology*, Career Choice ; Fellowships and Scholarships ; Humans ; Leadership ; Radiation Oncologists ; Surveys and Questionnaires